ACTRN12624001029583CompletedUnknown
A Double Blind Study to Evaluate a Novel Urine Metabolic Test (MyCellHealth) to Determine Possible Abnormal Cell Metabolism in adults 40 - 80 years old
ATH (Australia) Pty Ltd0 sites100 target enrollmentStarted: August 26, 2024Last updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Completed
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 40 Years to 80 Years (—)
- Sex
- All
Inclusion Criteria
- •Cohort One.
- •1.Attending one of the Specialist clinics involved in the study.
- •2.Male or female aged between 40 and 80 inclusive.
- •3.Otherwise healthy and not known to have malignancy or following appropriate testing to have benign disease as adjudicated by the participant’s doctor.
- •Cohort Two:
- •1.Attending one of the Specialist clinics involved in the study.
- •2.Male or female aged between 40 and 80 inclusive.
- •3.Known malignancy determined by the participant’s study doctor by way of routine diagnosis including, but not limited to physical examination, biopsy, pathology and/or imaging.
Exclusion Criteria
- •To be eligible to participate in the study, participants from all cohorts had to meet none of the following:
- •1.Terminally ill stage or palliative
- •2.Diagnosed with cancer and currently undergoing chemotherapy, radiation or surgery (not including biopsy)
- •3.Currently pregnant, menstruating and or breast feeding
- •4.Currently taking sulphur containing medications
- •5.Diagnosed with lupus
- •6.Prone to UTIs or have had a suspected or diagnosed UTI in the past 7 days.
Investigators
Similar Trials
Not yet recruiting
Phase 4
A CLINICAL STUDY ON ULTRASOUND GUIDED CONTINUOUS SUPRAINGUINAL FASCIA BLOCK INFUSION AND CONTINUOUS FEMORAL NERVE BLOCK INFUSION FOR POST SURGERY PAIN IN PATIENTS UNDERGOING HIP REPLACEMENT DONE UNDER GENERAL ANAESTHESIACTRI/2023/10/058647SRM INSTITUTES FOR MEDICAL SCIENCE
Completed
Not Applicable
Safety and clinical effects of IDX12899 in HIV-1 infectioChronic HIV-1 infectionInfections and InfestationsISRCTN89417804Idenix Pharmaceuticals (USA)40
Completed
Phase 2
Effects of memantine in Dacryocystorhinostomyacute post operative pain.Acute painIRCT2016011810599N5Vice chancellor for research Iran University of Medical Sciences, Hemmat expressway, Tehran60
Completed
Phase 2
Effects of regenerative agents injection in knee osteoarthrosisknee osteoarthrosis.Primary unilateral knee arthrosisIRCT2014101810599N2Vice chancellor for research- Iran University of Medical Sciences-40
Not yet recruiting
Phase 3
Management of chronic stable angina with an integrated approach of allopathic and ayurvedic medicationsCTRI/2023/06/054147Shathyu Ayurveda Pvt Ltd